Benchmark’s Bold Call: Semler Scientific Soars with $101 Target as Bitcoin Treasury Bet Pays Off
Wall Street wakes up to a crypto-curious healthcare play.
Semler Scientific just scored a bullish endorsement from Benchmark—complete with a street-high $101 price target—after pivoting its treasury strategy to Bitcoin. Because nothing says 'stable growth' like doubling down on digital asset volatility.
The move echoes MicroStrategy's infamous BTC gambit, but with a twist: This time, analysts are actually cheering. Maybe because they've run out of traditional companies to hype.
Key details buried in the fine print: Zero mention of how they'll handle the next 50% BTC drawdown. But hey—when the Fed's printing press is on fire, why not warm your hands with some Satoshis?